Clinical trial
Long-Term Valcyte Therapy in Transplant Patients and the Development of Ganciclovir Resistant CMV
NCT00225394 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Valcyte Therapy in Transplant Patients and the Development of Ganciclovir Resistant CMV
- Lead sponsor
- University of Massachusetts, Worcester
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- July 31, 2006
- Enrollment
- 100
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cmv disease, death, rejection, viral resistance